Q&A: Bain Capital takes Gangnam Style to China

Jonathan Zhu explains how Bain Capital plans to take established Korean botox firm, Hugel and inject it into a larger market, China, where medical beauty is booming.

The “Korean wave” of cultural influence, or hallyu in Korean, is taking Asia by storm. In China alone, Korean K-drama actors like Song Joong-ki and YoonA and members of Korean boy bands like EXO are A-list celebrities.

Private equity firm Bain Capital plans to ride that wave, using Korean brands’ popularity to sell the products of its portfolio companies to China’s burgeoning middle class.

“Koreans have become leaders in developing new products, new technology, new ways to consume, ways to improve one’s own self-image and wellbeing,” said Jonathan Zhu, managing director of Bain Capital, in an interview with FinanceAsia.

Global cosmetics...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222